Ken Griffin’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-21,637
Closed -$25.5K 15672
2023
Q4
$25.5K Buy
+21,637
New +$28.9K ﹤0.01% 12404
2023
Q3
Sell
-11
Closed -$40 15359
2023
Q2
$40 Buy
+11
New +$41 ﹤0.01% 14238
2022
Q4
Sell
-3,957
Closed -$19K 15606
2022
Q3
$19K Buy
3,957
+1,428
+56% +$10K ﹤0.01% 12098
2022
Q2
$27K Sell
2,529
-7,206
-74% -$62.9K ﹤0.01% 12284
2022
Q1
$133K Buy
+9,735
New +$169K ﹤0.01% 11986
2021
Q4
Sell
-2,074
Closed -$48.9K 15003
2021
Q3
$37K Buy
+2,074
New +$38.9K ﹤0.01% 13507

Other funds holding BTCY

Ken Griffin's BTCY Position: Q1 2024 in Review

Ken Griffin sold out of Biotricity, Inc. Common Stock (BTCY) in Q1 2024, closing a stake of 21,637 shares — an estimated $25.5K sold.

Ken Griffin first reported a position in BTCY in Q3 2021 and held it in 6 quarters. The position peaked at $133K in Q1 2022. 18 funds tracked by Wall St. Rank hold BTCY as of Q1 2024.

  • Ken Griffin reported no remaining Biotricity, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Ken Griffin sold 21,637 Biotricity, Inc. Common Stock shares in Q1 2024, an estimated $25.5K.
  • Ken Griffin first reported a position in Biotricity, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • Ken Griffin's Biotricity, Inc. Common Stock position peaked at $133K in Q1 2022.
  • 18 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.